Yarbrough Capital, LLC - Q4 2023 holdings

$1.91 Billion is the total value of Yarbrough Capital, LLC's 203 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was - .

 Value Shares↓ Weighting
FUSN NewFUSION PHARMACEUTICALS INC$738,74076,872
+100.0%
0.04%
DV NewDOUBLEVERIFY HLDGS INC$419,10811,395
+100.0%
0.02%
CHWY NewCHEWY INCcl a$409,98117,350
+100.0%
0.02%
DT NewDYNATRACE INC$386,7687,072
+100.0%
0.02%
HOLX NewHOLOGIC INC$355,3924,974
+100.0%
0.02%
IT NewGARTNER INC$304,950676
+100.0%
0.02%
DOCS NewDOXIMITY INCcl a$240,3598,572
+100.0%
0.01%
AZEK NewAZEK CO INCcl a$224,7195,875
+100.0%
0.01%
TMDX NewTRANSMEDICS GROUP INC$200,5612,541
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-01-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC11Q2 202425.3%
ALPHABET INC11Q2 20249.0%
AMAZON COM INC11Q2 202413.5%
NVIDIA CORPORATION11Q2 202416.7%
VANGUARD INDEX FDS11Q2 20246.6%
META PLATFORMS INC11Q2 20245.9%
VANGUARD INDEX FDS11Q2 20245.2%
MICROSOFT CORP11Q2 20243.1%
VANGUARD INTL EQUITY INDEX F11Q2 20242.9%
VANGUARD WORLD FDS11Q2 20242.8%

View Yarbrough Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-07-17
N-PX2024-07-17
13F-HR2024-04-10
13F-HR2024-01-12
13F-HR2023-10-12
13F-HR/A2023-08-25
13F-HR2023-07-13
13F-HR2023-04-13
13F-HR2023-01-12
13F-HR2022-11-03

View Yarbrough Capital, LLC's complete filings history.

Compare quarters

Export Yarbrough Capital, LLC's holdings